The sweat test for the diagnosis of fibrocystic disease of the pancreas owes its origin to an observation made during the heat wave of 1948 in New York (Kessler and Andersen, 1951 ) that more than half of the children admitted to hospital with signs of heat prostration were cases of fibrocystic disease of the pancreas. Although the serum sodium and chloride concentrations were much reduced the children had no history of prolonged vomiting, intestinal loss, kidney or adrenal dysfunction. It was postulated that there was some derangement of the sweating mechanism and that excessive electrolyte loss may have occurred through the skin.
In 1953 a preliminary report was published of the sodium and chloride concentrations in the sweat from eight patients with fibrocystic disease of the pancreas together with those from a similar number of control patients of the same age group (Darling, di Sant'Agnese, Perera, and Andersen) . This showed that the former group excreted four to five times as much sodium and chloride in the sweat as did the controls. Di Sant'Agnese, Darling, Perera, and Shea (1953) March, 1955, to March, 1956 , nine patients between the ages of 2 weeks and 7 years with fibrocystic disease of the pancreas were available for study. In five, the diagnosis was made on the clinical assessment supported by the laboratory findings of absent or low duodenal trypsin, and the presence of large amounts of neutral fat in the stools with low fat absorption. In the other four cases the diagnosis was made on clinical grounds supported by the lipiodol test, and also the trypsin activity of the faeces.
Control patients included those with steatorrhoea, failure to thrive, and chronic respiratory lesions. The diagnosis of fibrocystic disease of the pancreas was ruled out in these patients either by the presence of faecal and duodenal trypsin in normal amounts or by a lipiodol test and/or normal fat absorption.
Results Table I shows the range of concentration of sodium and chloride in 12 samples of sweat from nine patients with fibrocystic disease together with 40 samples from control patients. Fig. 1 gives the distribution of these figures. Table III gives the results of fat balance tests, faecal and duodenal tryptic activity, lipiodol tests, and concentration of sodium and chloride in the sweat from 10 patients with steatorrhoea, i.e., five patients with coeliac disease and five with fibrocystic disease of the pancreas.
The fat balance tests on the patients with steatorrhoea show the typical high fat output with low percentage absorption compared with the control group. Faecal and duodenal tryptic activity in patients with coeliac disease is comparable with that of the control patients, while the children with fibrocystic disease of the pancreas show, on the whole, less tryptic activity. Similarly, the lipiodol tests performed on patients with coeliac disease show the same degree of lipase activity as do the control series, whereas those on patients with fibrocystic disease of the pancreas show none or only slight lipase activity.
The sodium and chloride concentrations of the sweat of the control patients and those with steatorrhoea fall in the same range, whereas those from the patients with fibrocystic disease are four to five times as high as these other two groups.
Discussion
All of the nine cases of fibrocystic disease that we examined showed a persistently high level of sweat sodium and chloride content. These levels were beyond any found in the normal series. The findings confirm completely those made by di Sant'Agnese et al.
We found no relationship between the degrees of pancreatic and pulmonary involvement and the levels of sweat electrolytes. The same high levels were shown in the sweat from two cases of meconium ileus at 6 and 8 weeks of age respectively, as in the older well-developed cases. This again confirms the findings of the American workers (di Sant'Agnese et al., 1953) .
The possible cause of this electrolyte abnormality of sweat in the fibrocystic syndrome has been discussed at length by di Sant'Agnese (1955) .
This abnormality would appear to be an inherited factor, for some parents of affected children show similar high sweat sodium and chloride concentrations, but it is not known if these parents have been affected in this way throughout the whole of their lives (Shwachman, 1955) .
Our findings suggest that the occurrence of high sweat electrolyte concentrations together with relevant clinical features is diagnostic for fibrocystic disease of the pancreas.
Patients with adrenal insufficiency may have high sweat electrolytes, but these revert to normal or subnormal levels on treatment with D.O.C.A. or A.C.T.H. (Conn, 1949) . Neither of these drugs has any significant effect on the sweat electrolytes in fibrocystic disease (di Sant'Agnese, 1955 
